成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 683-57-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 683-57-8
Chemical Structure| 683-57-8
Structure of 683-57-8 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 683-57-8 ]

Related Doc. of [ 683-57-8 ]

Alternatived Products of [ 683-57-8 ]
Product Citations

Product Citations

Nkomba, Gaofenngwe ;

Abstract: Despite the availability of various classes of antiepileptic drugs (AEDs), about one third of epileptic patients do not experience satisfactory seizure control with present treatments. This has been an important drive in the search for alternative epilepsy treatment. The endogenous nucleoside adenosine is a known anticonvulsant through activation of adenosine A1 receptors. The development of adenosine derivatives such as N6-cyclohexyladenosine (CHA) as anticonvulsants had limitations which include pronounced peripheral side effects, mainly cardiovascular effects. Over the years, non-nucleoside agonists have been investigated as an alternative set of compounds which are highly potent and selective to specific adenosine receptor (AR) subtypes. The aim of this study was to investigate the use of amino-3,5-dicyanopyridine and thieno[2,3- b]pyridine derivatives as potential A1 AR agonists. A total of 23 test compounds were synthesised (6a–s and 7a–d) and 7 of these were novel (6d and 6k–p), while 4 compounds (7a–d) have been synthesised before but have never been tested for AR affinity. The effect of intramolecular cyclisation that occurs during synthesis of thieno[2,3-b]pyridines from the intermediate compounds, amino-3,5-dicyanopyridines, in relation to AR binding was evaluated. Overall, amino-3,5-dicyanopyridine displayed superior activity towards rA1 ARs compared to thieno[2,3]pyridines. The general poor activity of thieno[2,3-b]pyridines suggest that the intramolecular cyclisation results in molecular stiffening or rigidity which negatively affects binding to the receptors, perhaps, due to steric hindrance. For instance, compound 6f (open ring) had a six-fold better inhibition constant (Ki) value of 48 nM for the A1 subtype compared to its closed ring counterpart compound 7d (rA1Ki = 305 nM). Generally, most amino-3,5- dicyanopyridines exhibited greater affinity toward the rA1 AR (Ki

Keywords: Epilepsy ; Antiepileptic drugs ; Adenosine A1/A2A receptor agonists ; Amino-3 ; 5- dicyanopyridine derivatives ; Thieno[2 ; 3-b]pyridine derivatives ; Intramolecular cyclisation

Purchased from AmBeed: ; ;

Product Details of [ 683-57-8 ]

CAS No. :683-57-8 MDL No. :MFCD00008025
Formula : C2H4BrNO Boiling Point : -
Linear Structure Formula :- InChI Key :JUIKUQOUMZUFQT-UHFFFAOYSA-N
M.W : 137.96 Pubchem ID :69632
Synonyms :

Calculated chemistry of [ 683-57-8 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 5
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.5
Num. rotatable bonds : 1
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 22.51
TPSA : 43.09 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.51 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.58
Log Po/w (XLOGP3) : -0.52
Log Po/w (WLOGP) : -0.13
Log Po/w (MLOGP) : -0.14
Log Po/w (SILICOS-IT) : 0.11
Consensus Log Po/w : -0.02

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.3
Solubility : 68.9 mg/ml ; 0.499 mol/l
Class : Very soluble
Log S (Ali) : 0.08
Solubility : 167.0 mg/ml ; 1.21 mol/l
Class : Highly soluble
Log S (SILICOS-IT) : -0.7
Solubility : 27.7 mg/ml ; 0.201 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.56

Safety of [ 683-57-8 ]

Signal Word:Danger Class:8,6.1
Precautionary Statements:P280-P301+P310-P305+P351+P338-P310 UN#:2923
Hazard Statements:H301-H314 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 683-57-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 683-57-8 ]

[ 683-57-8 ] Synthesis Path-Downstream   1~4

  • 1
  • [ 683-57-8 ]
  • [ 7768-28-7 ]
  • [ 176435-64-6 ]
  • 2
  • [ 683-57-8 ]
  • [ 39987-25-2 ]
  • (4-methyloxycarbonylmethyl)piperazine-2,6-dione [ No CAS ]
  • 3
  • [ 683-57-8 ]
  • [ 13589-72-5 ]
  • [ 1169561-46-9 ]
  • 4
  • [ 683-57-8 ]
  • [ 403-01-0 ]
  • C10H10FNO4 [ No CAS ]
YieldReaction ConditionsOperation in experiment
71% With potassium carbonate; In N,N-dimethyl-formamide; at 65℃; for 1h; [0710] 2-Bromoacetamide (0.46 g, 3.4 mmol) was added to methyl 3-fluoro-4- hydroxybenzoate (0.29 g, 1.7 mmol) and potassium carbonate (0.70 g, 5.0 mmol) in DMF (1 mL), and the mixture was heated to 65 °C for lh. The mixture was diluted with EA. and the organic phase was washed with water and brine, dried over anhydrous Na2S0 and concentrated. Compound 380-1 was crystallized from EA and collected by filtration (0.27 g, 71percent). NMR (400 MHz, dmso-i/6): delta 7.67-7.42 (m, 2H), 7.50 (br. s, 1H), 7.38 (br. s, 1H), 7.1 1 (t, J = 8.62, l H), 4.62 (s, 2H), 3.79 (s, 3H).
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 683-57-8 ]

Aliphatic Chain Hydrocarbons

Chemical Structure| 5468-77-9

[ 5468-77-9 ]

2-Bromo-N,N-dimethylacetamide

Similarity: 0.67

Chemical Structure| 7462-74-0

[ 7462-74-0 ]

2-Bromo-2-methylpropanamide

Similarity: 0.59

Chemical Structure| 2576-47-8

[ 2576-47-8 ]

2-Bromoethylamine hydrobromide

Similarity: 0.56

Chemical Structure| 1138445-61-0

[ 1138445-61-0 ]

2-Bromo-N-hexadecylacetamide

Similarity: 0.55

Chemical Structure| 99584-96-0

[ 99584-96-0 ]

2,5-Dibromohexanediamide

Similarity: 0.53

Bromides

Chemical Structure| 5468-77-9

[ 5468-77-9 ]

2-Bromo-N,N-dimethylacetamide

Similarity: 0.67

Chemical Structure| 7462-74-0

[ 7462-74-0 ]

2-Bromo-2-methylpropanamide

Similarity: 0.59

Chemical Structure| 2576-47-8

[ 2576-47-8 ]

2-Bromoethylamine hydrobromide

Similarity: 0.56

Chemical Structure| 1138445-61-0

[ 1138445-61-0 ]

2-Bromo-N-hexadecylacetamide

Similarity: 0.55

Chemical Structure| 99584-96-0

[ 99584-96-0 ]

2,5-Dibromohexanediamide

Similarity: 0.53

Amides

Chemical Structure| 5468-77-9

[ 5468-77-9 ]

2-Bromo-N,N-dimethylacetamide

Similarity: 0.67

Chemical Structure| 7462-74-0

[ 7462-74-0 ]

2-Bromo-2-methylpropanamide

Similarity: 0.59

Chemical Structure| 1138445-61-0

[ 1138445-61-0 ]

2-Bromo-N-hexadecylacetamide

Similarity: 0.55

Chemical Structure| 99584-96-0

[ 99584-96-0 ]

2,5-Dibromohexanediamide

Similarity: 0.53

Chemical Structure| 79-05-0

[ 79-05-0 ]

Propionamide

Similarity: 0.50

Amines

Chemical Structure| 5468-77-9

[ 5468-77-9 ]

2-Bromo-N,N-dimethylacetamide

Similarity: 0.67

Chemical Structure| 7462-74-0

[ 7462-74-0 ]

2-Bromo-2-methylpropanamide

Similarity: 0.59

Chemical Structure| 2576-47-8

[ 2576-47-8 ]

2-Bromoethylamine hydrobromide

Similarity: 0.56

Chemical Structure| 1138445-61-0

[ 1138445-61-0 ]

2-Bromo-N-hexadecylacetamide

Similarity: 0.55

Chemical Structure| 99584-96-0

[ 99584-96-0 ]

2,5-Dibromohexanediamide

Similarity: 0.53

; ;